Régis Goulart Rosa

Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19

Bruno Martins Tomazini, Israel Silva Maia, Alexandre Biasi Cavalcanti et al. · JAMA · 2020 · 1.3K citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +13

Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19

Alexandre Biasi Cavalcanti, Fernando G Zampieri, Régis Goulart Rosa et al. · New England Journal of Medicine · 2020 · 1.1K citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial

Renato D. Lópes, Pedro Gabriel Melo de Barros e Silva, Remo H.M. Furtado et al. · The Lancet · 2021 · 496 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +12

Effect of tocilizumab on clinical outcomes at 15 days in patients with severe or critical coronavirus disease 2019: randomised controlled trial

Viviane Cordeiro Veiga, João Antônio Gonçalves Garreta Prats, Danielle Leão Cordeiro de Farias et al. · BMJ · 2021 · 408 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial

Remo H.M. Furtado, Otávio Berwanger, Henrique Fonseca et al. · The Lancet · 2020 · 372 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9